⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Starting GLP-1 medications means becoming familiar with a set of blood tests you will need regularly for the rest of your treatment. Most Indian patients receive these test results without a clear explanation of what each number means, which changes are expected from GLP-1 therapy, which changes are concerning, and what they should actually ask their doctor.
This guide demystifies every blood test relevant to GLP-1 therapy in an Indian clinical context — using Indian laboratory reference ranges, Indian brand names, and practical guidance you can use at your next appointment.
**Consult your healthcare provider before starting any medication.**
---
Before your first dose, your doctor should ideally order the following tests. If they have not, you can proactively request them.
| Test | Why It Matters | Indian Reference Range |
|------|---------------|----------------------|
| HbA1c | Baseline glycaemic control | Normal: <5.7%; Pre-diabetes: 5.7–6.4%; Diabetes: ≥6.5% |
| Fasting blood glucose (FBS) | Baseline sugar level | Normal: 70–100 mg/dL |
| Kidney function test (KFT) — creatinine + eGFR | GLP-1 requires dose adjustment in kidney disease | Creatinine: M 0.7–1.3, F 0.5–1.0 mg/dL |
| Liver function test (LFT) — ALT, AST | Baseline liver status | ALT: 7–56 U/L; AST: 10–40 U/L |
| Lipid profile | GLP-1 improves lipids; baseline needed | LDL <100 mg/dL ideal; TG <150 mg/dL |
| TSH (thyroid) | Thyroid affects weight and metabolism | 0.4–4.0 mIU/L |
| Complete blood count (CBC) | Baseline; GLP-1 can cause B12 deficiency | Reference varies by lab |
| Urine albumin:creatinine ratio (UACR) | Early kidney damage marker in diabetics | <30 mg/g normal |
| Serum Vitamin B12 | Often deficient in Indians; GLP-1 may worsen | >200 pg/mL (some labs use >300 pg/mL) |
| Vitamin D (25-OH) | Deficient in 70–80% of Indians; affects metabolism | >30 ng/mL sufficient |
---
HbA1c (also called glycated haemoglobin) measures your average blood glucose over the past 2–3 months. It is the single most important marker for GLP-1 treatment success in diabetic patients.
| Timepoint | Typical HbA1c Reduction |
|-----------|------------------------|
| 3 months | 0.5–1.5% reduction |
| 6 months | 1.0–2.0% reduction |
| 12 months | 1.5–2.5% reduction (on full dose) |
For example: if your HbA1c was 9.0% when you started, expect it to be approximately 7.0–8.0% at 12 months on semaglutide 1 mg.
**GLP-1 and HbA1c targets in India:**
Many Indian patients expect to see HbA1c improvement at their 1-month check-up. This is not how HbA1c works — it reflects a 2–3 month average. The first meaningful HbA1c check should be at 3 months after starting GLP-1.
---
GLP-1 medications are generally kidney-protective in diabetic patients. In clinical trials, semaglutide reduced urine albumin levels (a marker of kidney damage) by up to 46% compared to placebo. This is one of the major long-term benefits for Indian diabetics, who have very high rates of diabetic nephropathy.
| Kidney Marker | Expected Change on GLP-1 |
|--------------|-------------------------|
| Serum creatinine | Stable or modest improvement |
| eGFR (estimated GFR) | Stable or mild improvement in most patients |
| UACR (albumin:creatinine) | Typically decreases (protective effect) |
| Blood urea nitrogen (BUN) | Stable in most patients |
Alert your doctor if:
---
GLP-1 medications frequently improve liver function in patients with non-alcoholic fatty liver disease (NAFLD), which affects an estimated 38–40% of Indian adults with obesity.
| Liver Marker | Expected Change on GLP-1 |
|-------------|-------------------------|
| ALT (SGPT) | Decreases significantly in NAFLD patients (often 20–50% reduction) |
| AST (SGOT) | Similar improvement in NAFLD |
| GGT | Typically decreases |
| Total bilirubin | Usually unchanged |
| Alkaline phosphatase | Usually unchanged |
Alert your doctor if:
---
GLP-1 medications have a modest but clinically significant effect on lipids. Indian patients on GLP-1 commonly see improvements across all lipid parameters.
| Lipid Marker | Expected Change |
|-------------|----------------|
| LDL cholesterol | Decrease of 5–10 mg/dL |
| HDL cholesterol | Slight increase or stable |
| Triglycerides | Decrease of 10–20% |
| Total cholesterol | Modest decrease |
**Important:** GLP-1 is not a primary treatment for dyslipidaemia. If your lipids remain above target (LDL >100 mg/dL in diabetics), statins or other lipid medications may be required alongside GLP-1.
---
All GLP-1 medications carry a precautionary warning related to thyroid C-cells (medullary thyroid carcinoma) based on rodent studies, though large human studies have not confirmed this risk.
More practically relevant for Indian patients: **weight loss from GLP-1 changes your thyroxine requirements** if you are on levothyroxine (Thyronorm, Eltroxin). As weight decreases, the same levothyroxine dose may become relatively too high.
**TSH monitoring schedule for thyroid patients on GLP-1:**
---
GLP-1 medications do not directly cause B12 deficiency. However:
**Check B12 at baseline and then annually.** Indian vegetarians on GLP-1 + metformin are at highest risk.
**Signs of B12 deficiency:** tingling or numbness in hands/feet, fatigue, poor memory, mouth ulcers, sore tongue.
---
GLP-1 medications may have modest bone-protective effects, but the reduced food intake they cause can decrease calcium and Vitamin D absorption. Indian patients already have some of the world's highest rates of Vitamin D deficiency (estimated 70–80% of urban Indians).
**Check Vitamin D at baseline** and supplement if below 30 ng/mL. Standard supplementation in India is Vitamin D3 60,000 IU once weekly for 8–12 weeks, then maintenance dose.
---
GLP-1 medications do not directly affect red blood cell, white blood cell, or platelet counts. However, a CBC is valuable as:
---
Print this list and hand it to your doctor or give it to the lab:
1. HbA1c
2. Fasting blood glucose
3. Kidney function test (serum creatinine, eGFR, urea)
4. Urine albumin:creatinine ratio (spot sample is fine)
5. Liver function test (ALT, AST, bilirubin)
6. Lipid profile (LDL, HDL, TG, total cholesterol)
7. TSH (if you have thyroid disease or if not tested in 6 months)
8. Serum B12
9. Vitamin D (25-OH)
| Panel | Approximate Cost |
|-------|----------------|
| HbA1c alone | Rs 250–400 |
| Full diabetes panel (HbA1c + FBS + KFT + LFT + lipids) | Rs 1,000–2,000 |
| B12 + Vitamin D add-on | Rs 600–1,200 |
| UACR (urine test) | Rs 200–400 |
**SRL, Dr Lal PathLabs, Metropolis, Thyrocare** (India's major lab chains) offer bundled "diabetes monitoring packages" at reduced cost.
---
| Test | Frequency for Stable GLP-1 Users |
|------|----------------------------------|
| HbA1c | Every 3 months initially; every 6 months once stable |
| Kidney function + UACR | Every 6 months |
| Liver function | Every 6–12 months |
| Lipid profile | Annually |
| TSH (if on thyroid medication) | Every 6 months or with 5+ kg weight change |
| B12 | Annually |
| Vitamin D | Annually (or 3 months after starting supplementation) |
---
**Q: My HbA1c improved but my LDL hasn't changed much. Should I worry?**
GLP-1 has a moderate effect on LDL. If LDL remains above 100 mg/dL (standard target for diabetics in India), your doctor may need to add or increase statin therapy. GLP-1 is not a substitute for statins when LDL is significantly elevated.
**Q: My doctor doesn't order these tests. What should I do?**
Ask directly. Bring the list of tests from this article to your appointment. In India, patients can also request and pay for lab tests directly at major lab chains without a prescription (except for a few tests that require doctor's authorization). However, discuss results with your doctor.
**Q: I am vegetarian and my B12 has always been low. Will GLP-1 make it worse?**
GLP-1 alone does not directly lower B12. However, reduced appetite from GLP-1 means fewer B12-containing foods. If you are also on metformin, supplementation is strongly recommended. B12 injections (cyanocobalamin or methylcobalamin) are widely available in India at Rs 20–50 per injection.
**Consult your healthcare provider before starting any medication.**
